TABLE 2

Univariable and Multivariable Analyses of 30-Day Mortality, Composite 30-Day Complications, and SAEs (NSQIP-P 2012–2017)

30-d MortalityComposite 30-d ComplicationsSAEs
No. Mortality/n (%)acOR (95% CI)aOR (95% CI)No. Complications/n (%)acOR (95% CI)aOR (95% CI)No. SAEs/n (%)acOR (95% CI)aOR (95% CI)
Race
 White23/120 991 (0.02)ReferentReferent16 698/120 991 (13.8)ReferentReferent6913/120 991 (5.7)ReferentReferent
 AA13/19 675 (0.07)3.48 (1.76–6.87)3.43 (1.73–6.79)3320/19 675 (16.9)1.27 (1.22–1.32)1.18 (1.13–1.23)1213/19 675 (6.2)1.08 (1.02–1.15)1.07 (1.01–1.14)
Sex
 Female22/79 046 (0.03)ReferentReferent12 824/79 046 (16.2)ReferentReferent4364/79 046 (5.5)ReferentReferent
 Male21/93 503 (0.02)0.81 (0.44–1.47)0.64 (0.34–1.17)11 288/93 503 (12.1)0.71 (0.69–0.73)0.87 (0.85–0.90)5597/93 503 (6.0)1.09 (1.05–1.13)1.08 (1.04–1.13)
Age, mo
 >1217/139 380 (0.01)ReferentReferent19 352/139 380 (13.9)ReferentReferent7730/139 380 (5.5)ReferentReferent
 1–1214/27 276 (0.05)4.21 (2.07–8.54)4.68 (2.26–9.69)4006/27 276 (14.7)1.07 (1.03–1.11)1.17 (1.13–1.22)1664/27 276 (6.1)1.11 (1.05–1.17)1.13 (1.07–1.20)
 <112/5893 (0.20)16.73 (7.99–35.04)14.89 (6.65–33.30)754/5893 (12.8)0.91 (0.84–0.98)1.07 (0.98–1.16)567/5893 (9.6)1.81 (1.66–1.98)1.76 (1.60–1.92)
Work RVU
 ≤2530/145 945 (0.02)ReferentReferent12 686/145 945 (8.7)ReferentReferent8068/145 945 (5.5)ReferentReferent
 25–5011/26 124 (0.04)2.05 (1.03–4.09)1.87 (0.87–3.99)11 322/26 124 (43.3)8.03 (7.79–8.28)5.22 (5.04–5.40)1835/26 124 (7.0)1.29 (1.23–1.36)1.22 (1.15–1.30)
 >502/480 (0.42)20.35 (4.85–85.40)5.04 (1.11–22.80)104/480 (21.7)2.91 (2.34–3.61)2.15 (1.71–2.70)58/480 (12.1)2.35 (1.78–3.09)1.80 (1.36–2.38)
Year of surgery
 20125/19 287 (0.03)ReferentReferent2701/19 287 (14.0)ReferentReferent1168/19 287 (6.1)ReferentReferent
 20136/23 944 (0.03)0.97 (0.29–3.17)0.98 (0.30–3.22)3404/23 944 (14.2)1.02 (0.96–1.07)1.07 (1.00–1.13)1429/23 944 (6.0)0.98 (0.91–1.07)0.99 (0.91–1.07)
 20145/23 843 (0.02)0.81 (0.23–2.79)0.83 (0.24–2.87)3394/23 843 (14.2)1.02 (0.97–1.08)1.02 (0.97–1.09)1303/23 843 (5.5)0.90 (0.83–0.97)0.90 (0.83–0.98)
 201514/30 597 (0.05)1.77 (0.64–4.90)1.76 (0.63–4.90)4291/30 597 (14.0)1.00 (0.95–1.06)1.02 (0.96–1.07)1758/30 597 (5.7)0.95 (0.88–1.02)0.95 (0.88–1.03)
 20167/36 064 (0.02)0.75 (0.24–2.36)0.81 (0.26–2.54)4911/36 064 (13.6)0.97 (0.92–1.02)1.01 (0.96–1.07)2111/36 064 (5.9)0.96 (0.90–1.04)0.98 (0.91–1.05)
 20176/38 814 (0.02)0.60 (0.18–1.95)0.64 (0.20–2.11)5411/38 814 (13.9)0.99 (0.95–1.05)1.04 (0.98–1.10)2192/38 814 (5.6)0.93 (0.86–1.00)0.94 (0.88–1.01)
Case urgency
 Elective24/104 575 (0.02)ReferentReferent18 482/104 575 (17.7)ReferentReferent5931/104 575 (5.7)ReferentReferent
 Urgent11/40 118 (0.03)1.19 (0.59–2.44)1.47 (0.67–3.19)3441/40 118 (8.6)0.44 (0.42–0.45)0.98 (0.94–1.02)2440/40 118 (6.1)1.08 (1.03–1.13)1.18 (1.12–1.24)
 Emergent8/27 856 (0.03)1.25 (0.56–2.79)1.27 (0.54–2.98)2189/27 856 (7.9)0.40 (0.38–0.42)0.85 (0.80–0.89)1590/27 856 (5.7)1.01 (0.95–1.07)1.07 (1.01–1.14)
Operating time, min
 >25039/156 706 (0.02)ReferentReferent16 706/156 706 (10.7)ReferentReferent8746/156 706 (5.6)ReferentReferent
 ≥2504/15 827 (0.03)1.02 (0.36–2.84)1.12 (0.36–3.48)7402/15 827 (46.8)7.36 (7.11–7.63)3.39 (3.25–3.53)1214/15 827 (7.7)1.41 (1.32–1.50)1.39 (1.29–1.49)
  • We retained in our sample children (age <18 y old) with ASA class 1 or 2 who underwent inpatient surgical procedures. We used logistic regression to estimate the cORs and aORs. Multivariable analyses included all covariates in the table.

  • a Percentages are for the row.